Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Variation in clinical and patient-reported outcomes among complex heart failure with preserved ejection fraction phenotypes.

ESC heart failure - 1 Jun 2020

Flint Kelsey M, Shah Sanjiv J, Lewis Eldrin F, Kao David P

Abstract excerpt

AIMS: The aim of this study is to use six previously described heart failure with preserved ejection fraction (HFpEF) phenotypes to describe differences in (i) the biological response to spironolactone, (ii) clinical endpoints, and (iii) patient-reported health status by HFpEF phenotype and treatment arm in the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist Trial (TOPCAT)....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Heart Failure
Share to Hospitalization
Share to Patient Reported Outcome Measures

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Phenotype

Share to Stroke Volume

Share to Treatment Outcome

Share to United States

Source

Open in PubMed Open full text

Identifiers

PMID: 32160420
DOI: 10.1002/ehf2.12660
PMCID: PMC7261552

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Variation in clinical and patient-reported outcomes among complex heart failure with preserved ejection fraction phenotypes.PMID 32160420Read ↗

Phenotypes of heart failure with preserved ejection fraction and effect of spironolactone treatment.Semantic proximity Read ↗

Clinical Phenogroups in Heart Failure With Preserved Ejection Fraction: Detailed Phenotypes, Prognosis, and Response to Spironolactone.Semantic proximity Read ↗

Identification of distinct phenotypic clusters in heart failure with preserved ejection fractionSemantic proximity Read ↗

Phenotypic spectrum of heart failure with preserved ejection fraction.Semantic proximity Read ↗

Cardiac structure and function in heart failure with preserved ejection fraction: baseline findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist trial.Semantic proximity Read ↗

Heart failure with preserved ejection fraction: Classification based upon phenotype is essential for diagnosis and treatment.Semantic proximity Read ↗

Clinical Phenogroups in Heart Failure with Preserved Ejection Fraction.Semantic proximity Read ↗

Biological Phenotypes of Heart Failure With Preserved Ejection Fraction.Semantic proximity Read ↗

Biomarkers Correspond with Echocardiographic Phenotypes in Heart Failure with Preserved Ejection Fraction: A Secondary Analysis of the RELAX TrialSemantic proximity Read ↗

Key Phenotypes of Heart Failure with Preserved Ejection Fraction: Pathophysiologic Mechanisms and Potential Treatment Strategies.Semantic proximity Read ↗

Clinical Phenotypes in Heart Failure With Preserved Ejection Fraction.Semantic proximity Read ↗

Exercise Stress Echocardiography-Based Phenotyping of Heart Failure With Preserved Ejection Fraction.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.